Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Equity Ratio (2016 - 2025)

Rockwell Medical's Equity Ratio history spans 16 years, with the latest figure at 0.65 for Q4 2025.

  • For Q4 2025, Equity Ratio rose 17.58% year-over-year to 0.65; the TTM value through Dec 2025 reached 0.65, up 17.58%, while the annual FY2025 figure was 0.65, 17.58% up from the prior year.
  • Equity Ratio reached 0.65 in Q4 2025 per RMTI's latest filing, roughly flat from 0.64 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.65 in Q4 2025 to a low of 0.13 in Q1 2022.
  • Average Equity Ratio over 5 years is 0.37, with a median of 0.39 recorded in 2024.
  • The largest YoY upside for Equity Ratio was 479.59% in 2022 against a maximum downside of 134.07% in 2022.
  • A 5-year view of Equity Ratio shows it stood at 0.05 in 2021, then skyrocketed by 479.59% to 0.3 in 2022, then surged by 34.91% to 0.41 in 2023, then skyrocketed by 34.87% to 0.55 in 2024, then grew by 17.58% to 0.65 in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Equity Ratio are 0.65 (Q4 2025), 0.64 (Q3 2025), and 0.58 (Q2 2025).